CONCERT PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 93162
 
  
 
C07D HETEROCYCLIC COMPOUNDS 6598
 
  
 
C07B GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 145
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1382
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1138
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 11127
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 297
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 169
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0051,022 DEUTERATED PALBOCICLIBJun 29, 17Feb 22, 18[A61K, C07F, C07D]
2017/0281,616 MORPHINAN COMPOUNDSApr 14, 17Oct 05, 17[A61K, C07D]
2017/0216,296 METHODS OF TREATING HYPERGLYCEMIAApr 15, 15Aug 03, 17[A61K]
2017/0037,449 Morphinan CompoundsMar 11, 16Feb 09, 17[C12Q, C07D, G01N]
2017/0027,946 SUBSTITUTED XANTHINE DERIVATIVESOct 12, 16Feb 02, 17[A61K]
2015/0197,525 DEUTERATED DERIVATIVES OF RUXOLITINIBDec 15, 14Jul 16, 15[A61K, C07D]
2014/0296,263 SUBSTITUTED XANTHINE DERIVATIVESJul 19, 12Oct 02, 14[C07D]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9918987 Substituted xanthine derivativesOct 12, 16Mar 20, 18[A61K, C07D]
9868976 Morphinan compoundsMar 11, 16Jan 16, 18[A61K, C12Q, C07D, C12N, C07B, G01N]
9840463 Deuterated rigosertibJan 29, 16Dec 12, 17[A61K, A01N, C07C, C07B]
9815763 4-hydroxybutyric acid analogsJun 08, 15Nov 14, 17[A61K, C07C, C07B]
9783528 Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferaseSep 14, 15Oct 10, 17[A61K, C07D, C07B]
9776973 Deuterated momelotinibNov 30, 16Oct 03, 17[A61K, C07D, C07B]
9777009 Deuterated ibrutinibJul 27, 16Oct 03, 17[A61K, A01N, C07D, C07B]
9707218 Derivatives of pyrazole-substituted amino-heteroaryl compoundsAug 31, 15Jul 18, 17[A61K, C07D]
9708277 Inhibitors of cholesterol ester transfer proteinDec 28, 15Jul 18, 17[A61K, C07D]
9694017 Substituted triazolobenzodiazepinesFeb 09, 15Jul 04, 17[A61K, C07D, C07B]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0143,902 COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF PSEUDOBULBAR AFFECT, NEUROLGICAL DISEASES, INTRACTABLE AND CHRONIC PAIN AND BRAIN INJURYAbandonedNov 30, 15May 26, 16[A61K]
2016/0060,263 PYRAZINOISOQUINOLINE COMPOUNDSAbandonedNov 04, 15Mar 03, 16[C07D]
2016/0031,801 DEUTERATED 2-AMINO-3-HYDROXYPROPANOIC ACID DERIVATIVESAbandonedAug 04, 15Feb 04, 16[C07C]
2016/0024,084 DEUTERATED PALBOCICLIBAbandonedMar 12, 14Jan 28, 16[A61K, C07F, C07D]
2016/0009,732 DEUTERATED PACRITINIBAbandonedMar 12, 14Jan 14, 16[C07D]
2015/0376,665 PROCESS FOR PREPARING AN ENANTIOMERICALLY ENRICHED, DEUTERATED SECONDARY ALCOHOL FROM A CORRESPONDING KETONE WITHOUT REDUCING DEUTERIUM INCORPORATIONAbandonedJul 01, 15Dec 31, 15[C12P, C07D]
2015/0336,927 SUBSTITUTED DIOXOPIPERIDINYL PHTHALIMIDE DERIVATIVESAbandonedMay 29, 15Nov 26, 15[A61K, C07D]
2015/0328,220 METHODS OF TREATING CHRONIC KIDNEY DISEASE CHARACTERIZED BY MACROALBUMINURIAAbandonedMay 14, 15Nov 19, 15[A61K]
2015/0291,594 Deuterated PonatinibAbandonedAug 14, 13Oct 15, 15[A61K, C07D]
2015/0210,624 DEUTERATED 4-HYDROXYBUTYRIC ACID ANALOGSAbandonedAug 22, 13Jul 30, 15[A61K, C07C]
2015/0196,544 NOVEL BENZO[d][1,3]-DIOXOL DERIVATIVESAbandonedMar 10, 15Jul 16, 15[A61K]
2015/0166,601 DEUTERATED CARFILZOMIBAbandonedJul 12, 13Jun 18, 15[C07K]
2015/0158,870 POLYMORPHS OF 7-(TERT-BUTYL-D9)-3-(2,5-DIFLUOROPHENYL)-6-((1-METHYL-1H-1,2,4-TRIAZOL-5-YL)METHOXY)-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINEAbandonedMay 11, 13Jun 11, 15[C07D]
2015/0119,398 FORM 2 POLYMORPH OF 7-(TERT-BUTYL-D9)-3-(2,5-DIFLUOROPHENYL)-6-((1-METHYL-1H-1,2,4-TRIAZOL-5-YL)METHOXY)-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINEAbandonedMay 11, 13Apr 30, 15[C07D]
2015/0099,753 FORM 5 POLYMORPH OF 7-(TERT-BUTYL-D9)-3-(2,5-DIFLUOROPHENYL)-6-((1-METHYL-1H-1,2,4-TRIAZOL-5-YL)METHOXY)-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINEAbandonedMay 11, 13Apr 09, 15[C07D]
2014/0363,523 DEUTERATED ALPHA-LIPOIC ACIDAbandonedJan 17, 13Dec 11, 14[A61K, C07D]
2014/0213,553 CARBAMOYLPYRIDONE DERIVATIVESAbandonedMay 03, 12Jul 31, 14[A61K, C07D]
2014/0128,469 DEUTERATED N-BUTYL BUMETANIDEAbandonedMay 08, 12May 08, 14[C07C]
2014/0046,060 METHOD OF UTILIZING RECYCLED DEUTERIUM OXIDE IN THE SYNTHESIS OF DEUTERATED COMPOUNDSAbandonedSep 01, 11Feb 13, 14[C07D]
2014/0024,652 SUBSTITUTED TRIAZOLOPHTHALAZINE DERIVATIVESAbandonedSep 26, 13Jan 23, 14[A61K, C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.